Major constituent of plaques and tangles that occur in Alzheimers disease (AD) patients. Sequence (linear): H2N-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH Amino Acid Analysis: Confirms expected sequence Peptide Content: ~85.1 4% Solubility: H2O, DMSO, HFIP (1,1,1,3,3,3-hexafluoro-2-propanol). Storage and Stability: Lyophilized powder may be stored at 4C for short-term only. Stable for 12 months at -20C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Molekulargewicht:
4331
Reinheit:
~90% by HPLC and MS analysis
Formulierung:
Supplied as a lyophilized powder.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
